Gao, F. (2025) Research on the Causes and Preventive Measures of Pregnancy Complicated by Acute Abdomen. Open Journal of Obstetrics and Gynecology, 15, 97-107. doi: 10.4236/ojog.2025.151010 .
The clinical and hormonal phenotype of types II and IV is similar to that of patients with sporadic PA. Another original article (Liu et al.) focused on the evaluation of postoperative management of ...
The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.
The First International Symposium on Pheochromocytoma ... Localization studies should only follow reasonable clinical evidence of a tumor. Preoperative pharmacologic blockade of circulatory ...
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
Genes that are as yet unidentified will probably be found to cause hereditary pheochromocytoma or paraganglioma and increase the proportion of hereditary cases above that which has been already ...
Hallmark symptoms of Cushing disease, including abdominal striae and facial rounding, were more common among younger patients than older patients.